Karunakaran D, Rayner KJ. MicroRNAs in cardiovascular health: From order to disorder. Endocrinology. 2013;154(11):4000-9. [
Link] [
DOI:10.1210/en.2013-1299]
Jackson A L, Levin AA. Developing microRNA therapeutics: Approaching the unique complexities. Nucleic Acid Ther. 2012;22(4):213-25. [
Link]
Hertel J, Langenberger D, Stadler PF. Computational prediction of microRNA genes. Methods Mol Biol. 2014;1097:437-56. [
Link] [
DOI:10.1007/978-1-62703-709-9_20]
Thomson DW, Bracken CP, Goodall GJ. Experimental strategies for microRNA target identification. Nucleic Acids Res. 2011;39(16):6845-53. [
Link]
Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease?. Circ Res. 2012;110(3):483-95. [
Link] [
DOI:10.1161/CIRCRESAHA.111.247452]
Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Semin Oncol. 2011;38(6):724-33. [
Link] [
DOI:10.1053/j.seminoncol.2011.08.006]
Ajami M, Atashi A, Soleimani M, Ajami M, Kaviani S. Comparison of miR-24, miR-106aand miR-107 expression in identical twins of different ages. J Zanjan Univ Med Sci Health Serv. 2015;23(96):22-33. [Persian] [
Link]
Bakhshandeh B, Soleimani M, Hafizi M, Paylakhi SH, Ghaemi N. MicroRNA signature associated with osteogenic lineage commitment. Mol Biol Rep. 2012;39(7):7569-81. [
Link] [
DOI:10.1007/s11033-012-1591-2]
Bakhshandeh B, Soleimani M, Paylakhi SH, Ghaemi N. A microRNA signature associated with chondrogenic lineage commitment. J Genet. 2012;91(2):171-82. [
Link] [
DOI:10.1007/s12041-012-0168-0]
Bakhshandeh B, Hafizi M, Ghaemi N, Soleimani M. Down-regulation of miRNA-221 triggers osteogenic differentiation in human stem cells. Biotechnol Lett. 2012;34(8):1579-87. [
Link] [
DOI:10.1007/s10529-012-0934-3]
Cai B, Pan Z, Lu Y. The roles of microRNAs in heart diseases: A novel important regulator. Curr Med Chem. 2010;17(5):407-11. [
Link]
Silvestri P, Di Russo C, Rigattieri S, Fedele S, Todaro D, Ferraiuolo G, et al. MicroRNAs and ischemic heart disease: Towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Pat Cardiovasc Drug Discov. 2009;4(2):109-18. [
Link]
Malizia AP, Wang DZh. MicroRNAs in cardiomyocyte development. Wiley Interdiscip Rev Syst Biol Med. 2011;3(2):183-90. [
Link]
Li J, Dong X, Wang Zh, Wu J. MicroRNA-1 in cardiac diseases and cancers. Korean J Physiol Pharmacol. 2014;18(5):359-63. [
Link] [
DOI:10.4196/kjpp.2014.18.5.359]
Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38(2):228-33. [
Link]
Jayawardena TM, Egemnazarov B, Finch EA, Zhang L, Payne JA, Pandya K, et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ Res. 2012;110(11):1465-73. [
Link]
Mahmoodzadeh A, Pourfatollah A, Karimi M, Moazzeni S. Induction of tolerogenic murine dendritic cells by downregulating the co-stimulatory molecule of cd40 using lentivirus vector. J Zanjan Univ Med Sci Health Serv. 2014;22(94):1-10. [Persian] [
Link]
Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, Muth AN, et al. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 2007;129(2):303-17. [
Link]
Ranji N, Sadeghizadeh M, Shokrgozar MA, Bakhshandeh B, Karimipour M, Amanzadeh A, et al. MiR-17-92 cluster: An apoptosis inducer or proliferation enhancer. Mol Cell Biochem. 2013;380(1-2):229-38. [
Link]
Metcalf D, Carpinelli MR, Hyland C, Mifsud S, Dirago L, Nicola NA, et al. Anomalous megakaryocytopoiesis in mice with mutations in the c-Myb gene. Blood. 2005;105(9):3480-7. [
Link]
Lo KW, Ashe KM, Kan HM, Laurencin CT. The role of small molecules in musculoskeletal regeneration. Regen Med. 2012;7(4):535-49. [
Link] [
DOI:10.2217/rme.12.33]
Ahvaz HH, Soleimani M, Mobasheri H, Bakhshandeh B, Shakhssalim N, Soudi S, et al. Effective combination of hydrostatic pressure and aligned nanofibrous scaffolds on human bladder smooth muscle cells: Implication for bladder tissue engineering. J Mater Sci Mater Med. 2012;23(9):2281-90. [
Link]
Scarritt ME, Pashos NC, Bunnell BA. A review of cellularization strategies for tissue engineering of whole organs. Front Bioeng Biotechnol. 2015;3:43. [
Link]
Bakhshandeh B, Soleimani M, Hafizi M, Ghaemi N. A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells. Cytotechnology. 2012;64(5):523-40. [
Link] [
DOI:10.1007/s10616-012-9430-9]
Halff EF, Versteeg M, Brondijk TH, Huizinga EG. When less becomes more: Optimization of protein expression in HEK293-EBNA1 cells using plasmid titration - a case study for NLRs. Protein Expr Purif. 2014;99:27-34. [
Link] [
DOI:10.1016/j.pep.2014.03.010]
Huang F, Tang L, Fang ZhF, Hu XQ, Pan JY, Zhou ShH. MiR-1-mediated induction of cardiogenesis in mesenchymal stem cells via downregulation of Hes-1. BioMed Res Int. 2013;2013: ID 216286. [
Link]
Wang TY, Zhang QQ, Zhang X, Sun QL, Zhao CP, Wang XY. The effect of recombinant lentiviral vector encoding miR-145 on human esophageal cancer cells. Tumour Biol. 2015;36(12):9733-8. [
Link] [
DOI:10.1007/s13277-015-3743-1]
So KH, Han YJ, Park HY, Kim JG, Sung DJ, Bae YM, et al. Generation of functional cardiomyocytes from mouse induced pluripotent stem cells. Int J Cardiol. 2011;153(3):277-85. [
Link]
Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, et al. Generation of human melanocytes from induced pluripotent stem cells. PLoS One. 2011;6(1):e16182. [
Link]
